Extracellular Vesicle (EV) Proteomics in Corneal Regenerative Medicine
Proteomes · 03.10.2025 · 13 (4) · 49
DOI: 10.3390/proteomes13040049 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Proteomes, online erschienen am 03.10.2025. Verfasst von Zohreh Arabpour und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Science, University of Illinois, Chicago, IL 60612, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, Research to Prevent Blindness (RPB), National Institutes of Health (NIH).
Abstract (Originalsprache)
Corneal regeneration has gained growing interest in recent years, largely due to the limitations of conventional treatments and the persistent shortage of donor tissue. Among the emerging strategies, extracellular vehicles (EVs), especially those derived from mesenchymal stromal cells (MSCs), have shown great promise as a cell-free therapeutic approach. These nanoscale vesicles contribute to corneal healing by modulating inflammation, supporting epithelial and stromal regeneration, and promoting nerve repair. Their therapeutic potential is largely attributed to the diverse and bioactive proteomic cargo they carry, including growth factors, cytokines, and proteins involved in extracellular matrix remodeling. This review presents a comprehensive examination of the proteomic landscape of EVs in the context of corneal regenerative medicine. We explore the biological functions of EVs in corneal epithelial repair, stromal remodeling, and neurodegeneration. In addition, we discuss advanced proteomic profiling techniques such as mass spectrometry (MS) and liquid chromatography–mass spectrometry (LC-MS/MS), which have been used to identify and characterize the protein contents of EVs. This review also compares the proteomic profiles of EVs derived from various MSC sources, including adipose tissue, bone marrow, and umbilical cord, and considers how environmental cues, such as hypoxia and inflammation, influence their protein composition. By consolidating current findings, this article aims to provide valuable insights for advancing the next generation of cell-free therapies for corneal repair and regeneration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Science, University of Illinois, Chicago, IL 60612, USA.
- Department of Tissue Engineering, School of Medicine, Shahroud University of Medical Sciences, Shahroud 3614773955, Iran.
ORCID-Profile: Zohreh Arabpour, Amal Yaghmour, Majid Salehi, Elmira Jalilian, Mahmood Ghassemi, Victor H Guaiquil
Förderung
- NEI NIH HHS
- Research to Prevent Blindness (RPB)
- National Institutes of Health (NIH)
- Department of Defense - Vision Research Program, Congressionally Directed Medical Research Program
- Department of Defense – Vision Research Program, Congressionally Directed Medical Research Program
Zitieren
APA
Arabpour, Z., Niktinat, H., Hatami, F., Yaghmour, A., Yucel, Z. J., Ghalibafan, S., Massoumi, H., Bibak Bejandi, Z., Salehi, M., Jalilian, E., Ghassemi, M., Guaiquil, V. H., Rosenblatt, M., & Djalilian, A. R. (2025). Extracellular Vesicle (EV) Proteomics in Corneal Regenerative Medicine. Proteomes, 13(4), 49. https://doi.org/10.3390/proteomes13040049
Vancouver
Arabpour Z, Niktinat H, Hatami F, Yaghmour A, Yucel ZJ, Ghalibafan S, et al. Extracellular Vesicle (EV) Proteomics in Corneal Regenerative Medicine. Proteomes. 2025;13(4):49. doi:10.3390/proteomes13040049
BibTeX
@article{Arabpour2025,
author = {Arabpour, Zohreh and Niktinat, Hanieh and Hatami, Firouze and Yaghmour, Amal and Yucel, Zarife Jale and Ghalibafan, Seyyedehfatemeh and Massoumi, Hamed and Bibak Bejandi, Zahra and Salehi, Majid and Jalilian, Elmira and Ghassemi, Mahmood and Guaiquil, Victor H and Rosenblatt, Mark and Djalilian, Ali R},
title = {Extracellular Vesicle (EV) Proteomics in Corneal Regenerative Medicine},
journal = {Proteomes},
year = {2025},
volume = {13},
number = {4},
pages = {49},
doi = {10.3390/proteomes13040049}
}
EUVIMED